CONMED price to free cash flow CNMD

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 11.0×
10-year median: 35.2×
Against its 10-year history: 14th; percentile: 0 is its lowest day, 100 its highest
10-year range: 7.1× to 306×
Peer median: 30.5×

CONMED's price to free cash flow is 11.0× as of Oct 23, 2026.

That is below its ten-year median of 35.2×, lower than on 86% of days in the last ten years.

Over that time it ranged from 7.1× in Mar 2026 to 306× in Apr 2023.

The median for 4 medical device stocks of a similar size is 30.5×.

Price to free cash flow over time

median 35.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	11.0×	7.1×	11.4×
2025	8.5×	8.3×	13.3×
2024	13.1×	12.0×	91.5×
2023	89.8×	47.9×	306×
2022	45.4×	35.3×	56.1×
2021	49.8×	36.1×	75.3×
2020	46.3×	18.2×	52.3×
2019	52.0×	31.6×	100×
2018	31.8×	29.7×	39.4×
2017	31.8×	23.8×	62.4×
2016	61.4×	20.3×	500×
2015	24.5×	21.4×	34.8×
2014	25.0×	15.7×	25.0×
2013	16.9×	11.5×	16.9×
2012	11.7×	10.5×	14.0×

Against its peers

Companies in Medical - Devices nearest CONMED's size, closest first, today.

Company	Price to free cash flow
CNMDCONMED	11.0×
TMDXTransMedics	31.0×
ITGRInteger	38.4×
LIVNLivaNova	30.1×
ELMDElectromed	26.2×
Peer median	30.5×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on CONMED

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.